Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

tACS Treatment for Cognitive Impairments in Methamphetamine Addicts

NCT06292156 is registered in ClinicalTrials.gov with Beijing HuiLongGuan Hospital as lead sponsor.

NCT NCT06292156
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06292156 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
tACS Treatment for Cognitive Impairments in Methamphetamine Addicts
Lead sponsor
Beijing HuiLongGuan Hospital
Phase
Not applicable
Overall status
Completed
Start date
December 30, 2023
Completion date
December 30, 2024
Enrollment
68 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

methamphetamine abuse